The Series A funding will enable team expansion as SiPhox Health works towards FDA clearance for its SiPhox Home platform, which will offer a broad menu of proteins and hormone tests from a finger prick blood sample, with results in five minutes or less. In the meantime, SiPhox Health has launched a mail-in blood collection kit that measures 17 biomarkers for inflammation, metabolic, hormonal and cardiovascular health.

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

111 Terrace Hall Ave
Burlington, MA 01803
USA

Phone

Undisclosed

Website

www.siphoxhealth.com

Email Address

[email protected]

Overview

The SiPhox Health at-home test kit measures 17 blood biomarkers of inflammation, hormonal health, metabolic fitness, and cardiovascular health.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Diedrik Vermeulen

Co-Founder

Michael Dubrovsky

Browse more venture capital transactions:

Prev: 7/18/2023: Bureau venture capital transaction
Next: 7/19/2023: Renibus Therapeutics venture capital transaction

Share this article

News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary